Adverse Drug Reactions
Spectranetics Receives FDA Clearance to Market TURBO-Booster
Published in Medical Device Business Week, July 18th, 2007
Spectranetics Corporation (NASDAQ:SPNC) announced it has received clearance from the Food and Drug Administration (FDA) to market its TURBO-Booster(TM) product for the treatment of arterial stenoses and occlusions in the leg, which represents a broader indication for use as compared to current labeling of the existing peripheral laser catheters. The TURBO-Booster functions as a guiding catheter facilitating directed ablation of blockages in the main arteries at or above the knee. The TURBO-Booster combined with Turbo elite(TM) laser catheters allows for removal of large amounts of plaque material within the SFA and popliteal arteries.
The CELLO trial, the study...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- Arrhythmia
Medtronic Launches First Wireless Devices in Japan - Astigmatism
World Council of Optometry Awards ACUVUE ADVANCE, ACUVUE OASYS Brands With Global Seal of Acceptance for UV Absorbing Contact Lenses - Biomedical Engineering
CardioTech Announces Agreement to Sell Gish Biomedical to Medos Medizintechnik AG for a Purchase Price of $7.5 Million - Biomedical Engineering
Environmental Tectonics Corporation's BioMedical Division Announces Contract Award - Biomedical Engineering
U.S. Bioresearch Company Forms Partnership with Major Chinese University - Biomolecular Screening
Study results from Bayer Pharmaceuticals Corporation, Department of Research provide new insights into biomolecular screening - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
